Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,807 Cr.
- Current Price ₹ 999
- High / Low ₹ 1,227 / 262
- Stock P/E 92.9
- Book Value ₹ 54.0
- Dividend Yield 0.00 %
- ROCE 62.1 %
- ROE 76.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 18.5 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | |
|---|---|---|
| 0 | 61 | |
| 0 | 43 | |
| Operating Profit | 0 | 18 |
| OPM % | 30% | |
| 0 | 0 | |
| Interest | 0 | 3 |
| Depreciation | 0 | 1 |
| Profit before tax | 0 | 14 |
| Tax % | 25% | |
| 0 | 11 | |
| EPS in Rs | 0.00 | 8.12 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 76% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|
| Equity Capital | 0.10 | 13 | 18 |
| Reserves | 0 | 15 | 80 |
| 0 | 27 | 30 | |
| 0 | 9 | 15 | |
| Total Liabilities | 0 | 64 | 143 |
| 0 | 13 | 28 | |
| CWIP | 0 | 6 | 0 |
| Investments | 0 | 4 | 4 |
| 0 | 41 | 112 | |
| Total Assets | 0 | 64 | 143 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| -0 | 6 | |
| 0 | -23 | |
| 0 | 17 | |
| Net Cash Flow | 0 | 0 |
| Free Cash Flow | -0 | -14 |
| CFO/OP | 36% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 100 | |
| Inventory Days | 115 | |
| Days Payable | 45 | |
| Cash Conversion Cycle | 170 | |
| Working Capital Days | 101 | |
| ROCE % | 62% |
Insights
In beta| Jan 2026 | Mar 2027 (P) | |
|---|---|---|
| Installed Manufacturing Capacity million pieces per annum |
|
|
| Capacity Under Trial Production million pieces per annum |
||
| Existing Capacity Utilization million pieces per annum |
||
| Existing Capacity Utilization (%) % |
||
| IPO Proceeds Re-allocation to Working Capital INR Lakhs |
||
| IPO Proceeds Utilized (Total) INR Lakhs |
||
| IPO Unutilized Amount INR Lakhs |
||
| L1 GeM Tender Supply Volume (Condoms) pieces |
||
| L1 GeM Tender Supply Volume (Family Planning Items) pieces |
||
| Order Value (CMSS GeM Tender) INR |
||
| Projected Turnover for FY2025-26 INR Crores |
||
| Target Capacity Expansion (Noida Facility) million pieces per annum |
||
Extracted by Screener AI
Documents
Announcements
-
Preferential issue
30 April 2026 - Board approved preferential issue of 2,85,000 warrants to promoter Anupam Ghosh, raising up to ₹29.13 crore.
-
Outcome of Board Meeting
30 April 2026 - Board approved 2.85 lakh promoter warrants worth ₹29.13 crore, material RPTs, remuneration hikes, and EGM.
-
Issue of Securities
30 April 2026 - Board approved 2,85,000 warrants to promoter Anupam Ghosh at ₹1,022 each, raising up to ₹29.13 crore.
-
Amendment to AOA/MOA
30 April 2026 - Board approved MOA main object change to add contraceptives, sexual wellness and gloves, subject to shareholder approval.
-
Preferential issue
30 April 2026 - Board approved 2,85,000 warrants to promoter Anupam Ghosh at Rs. 1,022 each on April 30, 2026.
Annual reports
No data available.
Concalls
-
Mar 2026TranscriptAI SummaryPPT
Business Profile:[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.